Affy |
Affymetrix |
ACC |
Adrenocortical carcinoma |
BLCA |
Bladder Urothelial Carcinoma |
BRCA |
Breast invasive carcinoma |
CESC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
CHOL |
Cholangiocarcinoma |
COAD |
Colon adenocarcinoma |
DFS |
disease free survival |
DLBC |
Diffuse Large B-cell Lymphoma |
CTLA-4 |
cytotoxic T lymphocyte-associated protein 4 |
ESCA |
Esophageal carcinoma |
GBM |
Glioblastoma multiforme |
GEO |
Gene Expression Omnibus |
GO |
Gene Ontology |
GTEx |
(Genotype-Tissue Expression) |
HLA-G |
Human leukocyte antigen G |
HNSC |
Head and Neck squamous cell carcinoma |
KEGG |
Kyoto Encyclopedia of Genes and Genomes |
KICH |
Kidney Chromophobe |
KIRC |
Kidney renal clear cell carcinoma |
KIRP |
Kidney renal papillary cell carcinoma |
LAML |
Acute Myeloid Leukemia |
LGG |
Brain Lower Grade Glioma |
LIHC |
Liver hepatocellular carcinoma |
LUAD |
Lung adenocarcinoma |
LUSC |
Lung squamous cell carcinoma |
MESO |
Mesothelioma |
OS |
overall survival |
OV |
Ovarian serous cystadenocarcinoma |
PAAD |
Pancreatic adenocarcinoma |
PCPG |
Pheochromocytoma and Paraganglioma |
PD-1 (PDCD1) |
programmed cell death protein 1 |
PDAC |
Pancreatic ductal adenocarcinoma |
PRAD |
Prostate adenocarcinoma |
READ |
Rectum adenocarcinoma |
RNAseq |
RNA sequencing |
SARC |
Sarcoma |
SKCM |
Skin Cutaneous Melanoma |
STAD |
Stomach adenocarcinoma |
STES |
Stomach and Esophageal carcinoma |
TCGA |
The Cancer Genome Atlas |
TF |
transcription factor |
TGCT |
Testicular Germ Cell Tumors |
TPM |
transcripts per million |
THCA |
Thyroid carcinoma |
THYM |
Thymoma |
UCEC |
Uterine Corpus Endometrial Carcinoma |
UCS |
Uterine Carcinosarcoma |
UVM |
Uveal Melanoma |